These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12400895)

  • 1. Isoniazid-resistant cavitary tuberculosis in a physician following isoniazid prophylaxis.
    Karchmer TB; Phipps JD; Giannetta ET; Farr BM
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):622-5. PubMed ID: 12400895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of a careful examination of all persons in close contact with newly diagnosed infectious tuberculosis].
    Zodtke F; Fleisch F; Brunner H; Reinhart WH; Kuhn M
    Praxis (Bern 1994); 2004 Oct; 93(43):1775-80. PubMed ID: 15553898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.
    Livengood JR; Sigler TG; Foster LR; Bobst JG; Snider DE
    JAMA; 1985 May; 253(19):2847-9. PubMed ID: 3989958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis.
    Steiner P; Rao M; Mitchell M; Steiner M
    Am J Dis Child; 1985 Aug; 139(8):780-2. PubMed ID: 3927707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit.
    Ahn JG; Kim DS; Kim KH
    Am J Infect Control; 2015 Dec; 43(12):1292-5. PubMed ID: 26307044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis.
    Chierakul N; Saengthongpinij V; Foongladda S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S86-90. PubMed ID: 24772584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
    Steiner P; Rao M; Victoria M; Steiner M
    Am Rev Respir Dis; 1974 Sep; 110(3):306-11. PubMed ID: 4213311
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis exposure in a day-care center: recommended management.
    Smith KC
    South Med J; 2000 Sep; 93(9):877-80. PubMed ID: 11005346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
    J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of tuberculosis after apparently adequate chemoprophylaxis.
    Currie GP; Emmanuel FX; Ford D; Devereux G
    J Infect; 2005 Dec; 51(5):e305-8. PubMed ID: 16321645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hospital chemotherapy in the presence of isoniazid-resistant and multi-resistant causative organisms].
    Reimers D
    Prax Pneumol; 1973 Apr; 27(4):226-35. PubMed ID: 4633372
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Mycobacterium tuberculosis transmission from a pediatrician and initial compliance to prophylaxis of contacts in an outpatient pediatric clinic.
    Brassard P; Lamarre V
    Pediatr Infect Dis J; 2000 Oct; 19(10):968-72. PubMed ID: 11055598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary drug resistance in tuberculosis.
    Katz S
    JAMA; 1970 Jun; 212(12):2113-4. PubMed ID: 4986737
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.